CONCORD Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Concord Drugs Ltd

Watchlist Manager

Watchlist

Price: 71.53 INR 5.19% Market Closed

Market Cap: ₹942.8m

C	Concord Drugs Ltd BSE:538965	IN
Z	Zimmer Biomet Holdings, Inc XMUN:ZIM	US
L	Land Securities Group PLC OTC:LDSCY	UK
	Prada SpA HKEX:1913	IT
B	Blu Label Unlimited Group Ltd JSE:BLU	ZA
	Ares Capital Corp NASDAQ:ARCC	US
	Questor Technology Inc F:79Q	CA
A	Accelera Innovations Inc OTC:ACNV	US
W	WonpoongCorp KOSDAQ:008370	KR
	Petronet LNG Ltd BSE:532522	IN
P	Progress Software Corp SWB:PGR	US
	Molson Coors Beverage Co NYSE:TAP	US
H	High Quality Food SpA F:L24	IT
S	Siemens AG DUS:SIE	DE
S	Seera Holding Group SJSC SAU:1810	SA
W	Workday Inc F:W7D	US
O	Oconee Federal Financial Corp OTC:OFED	US
	UIE PLC F:I55	MT
U	Uranium Energy Corp AMEX:UEC	CA
	Spero Therapeutics Inc NASDAQ:SPRO	US
	Aland Equity Group Ltd ASX:AEG	AU

Profitability Summary

Concord Drugs Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

15%

Sustainable 3Y Average Gross Margin

21%

Declining Gross Margin

28% > 15%

Low Operating Margin

Low 3Y Average Operating Margin

Declining Operating Margin

9% > 5%

Low Net Margin

Low 3Y Average Net Margin

Declining Net Margin

4% > 2%

Negative Free Cash Flow Margin

-9%

Negative 3Y Average Free Cash Flow Margin

Declining Free Cash Flow Margin

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.